Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
8.51
-0.10 (-1.16%)
At close: Jun 20, 2025, 4:00 PM
8.77
+0.26 (3.06%)
After-hours: Jun 20, 2025, 7:52 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$1,430,295
Profits / Employee
-$2,181,000
Market Cap
105.58M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NKTR News
- 9 days ago - Nektar Therapeutics: 2 Data Readouts For REZPEG 2025 Could Establish Further POC - Seeking Alpha
- 10 days ago - AMBROSIA & NEKTAR Introduces Premium High-End Organic Food from Greece with a Commitment to Purity and Provenance - GlobeNewsWire
- 5 weeks ago - Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - PRNewsWire
- 6 weeks ago - Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Nektar Therapeutics Reports First Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire
- 3 months ago - Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference - PRNewsWire
- 3 months ago - Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Transcript - Seeking Alpha